Interim Safety And Efficacy Results From A Phase I/Ii Study Of Vaccination With Electrofused Allogeneic Dendritic Cells/Autologous Tumor-Derived Cells In Patients With Stage Iv Renal Cell Carcinoma.
JOURNAL OF CLINICAL ONCOLOGY（2004）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要